Home / Inspections / 1105823

FDA Inspection 1105823 — Aurobindo Pharma Limited

Aurobindo Pharma Limited — FEI 3007373532

The FDA completed an inspection of Aurobindo Pharma Limited on September 27, 2019 in Jedcherla Mandal, Mahabubnagar. The inspection was classified OAI (Official Action Indicated — objectionable conditions were found and regulatory action is recommended). Product area: Drugs.

Inspection Details

Classification
Official Action Indicated (OAI) (OAI)
End Date
September 27, 2019
Fiscal Year
2019
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Jedcherla Mandal, Mahabubnagar (India)

Facility

Other inspections at this facility

  • 1169446 (VAI Tue May 10 2022 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1022788 (NAI Sat Jun 24 2017 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 927596 (NAI Fri Mar 13 2015 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 787128 (NAI Tue Jun 19 2012 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 694644 (VAI Fri Jul 30 2010 00:00:00 GMT+0000 (Coordinated Universal Time))

FDA data resources